AllianceBernstein
SGYP

AllianceBernstein’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

AllianceBernstein’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-296,230
Closed -$504K – 3173
2018
Q3 		$504K Sell
296,230
-24,100
-8% -$43.1K ﹤0.01% 2615
2018
Q2 		$557K Buy
320,330
+4,300
+1% +$7.43K ﹤0.01% 2573
2018
Q1 		$578K Buy
316,030
+77,000
+32% +$163K ﹤0.01% 2479
2017
Q4 		$533K Sell
239,030
-435,300
-65% -$1.08M ﹤0.01% 2512
2017
Q3 		$1.96M Buy
674,330
+335,000
+99% +$1.14M ﹤0.01% 1864
2017
Q2 		$1.51M Buy
339,330
+69,800
+26% +$288K ﹤0.01% 2038
2017
Q1 		$1.26M Hold
269,530
– – ﹤0.01% 2126
2016
Q4 		$1.64M Hold
269,530
– – ﹤0.01% 1973
2016
Q3 		$1.49M Sell
269,530
-22,400
-8% -$105K ﹤0.01% 1993
2016
Q2 		$1.11M Buy
291,930
+94,800
+48% +$321K ﹤0.01% 2158
2016
Q1 		$544K Hold
197,130
– – ﹤0.01% 2390
2015
Q4 		$1.12M Hold
197,130
– – ﹤0.01% 2064
2015
Q3 		$1.04M Buy
197,130
+2,730
+1% +$21.1K ﹤0.01% 2146
2015
Q2 		$1.61M Buy
194,400
+111,800
+135% +$542K ﹤0.01% 1973
2015
Q1 		$382K Sell
82,600
-2,400
-3% -$7.8K ﹤0.01% 2591
2014
Q4 		$259K Sell
85,000
-9,400
-10% -$27.8K ﹤0.01% 2725
2014
Q3 		$263K Hold
94,400
– – ﹤0.01% 2692
2014
Q2 		$384K Sell
94,400
-23,600
-20% -$100K ﹤0.01% 2599
2014
Q1 		$627K Buy
118,000
+28,565
+32% +$160K ﹤0.01% 2356
2013
Q4 		$497K Sell
89,435
-11,154
-11% -$48.1K ﹤0.01% 2454
2013
Q3 		$453K Buy
100,589
+956
+1% +$4.29K ﹤0.01% 2523
2013
Q2 		$424K Buy
+99,633
New +$501K ﹤0.01% 2570

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OCM
Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AllianceBernstein's SGYP Position: Q4 2018 in Review

AllianceBernstein sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 296,230 shares — an estimated $504K sold.

AllianceBernstein first reported a position in SGYP in Q2 2013 and held it in 22 quarters. The position peaked at $1.96M in Q3 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • AllianceBernstein reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • AllianceBernstein sold 296,230 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $504K.
  • AllianceBernstein first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 22 quarters.
  • AllianceBernstein's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.96M in Q3 2017.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.